Martha Y Walkup, DO | |
1578 N Greenhill Rd, Mount Juliet, TN 37122-2454 | |
(615) 509-3366 | |
(615) 773-4502 |
Full Name | Martha Y Walkup |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 1578 N Greenhill Rd, Mount Juliet, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467571216 | NPI | - | NPPES |
4212957 | Other | TN | BLUE CROSS BLUE SHIELD OF TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | DO 0573 (Tennessee) | Primary |
2083X0100X | Preventive Medicine - Occupational Medicine | H2087 DO (Texas) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Martha Y Walkup, DO 1578 N Greenhill Rd, Mount Juliet, TN 37122-2454 Ph: (615) 509-3366 | Martha Y Walkup, DO 1578 N Greenhill Rd, Mount Juliet, TN 37122-2454 Ph: (615) 509-3366 |
News Archive
A new study has focused on antibody levels and cytokine profiles of COVID-19 patients with mild symptoms, pneumonia, and severe pneumonia.
Linking genetic material microRNAs with cells that regulate the immune system could one day lead to new therapies for treating cancer, infections and autoimmune diseases, according to a Henry Ford Hospital study.
Analysis published in Drug Discovery Today reveals the gap between animal models of Parkinson's disease and our understanding of the neurodegenerative processes underlying the disease, and calls for the implementation of modern, human biology-based technologies to better understand pathological processes and improve treatment outcome.
Researchers surveyed the parents of 277 children and found that only a quarter recognised when their offspring were overweight. Where children were obese, a third of mothers and 57% of fathers thought their sons and daughters were "about right".
A group of international cancer researchers led by investigators from Mayo Clinic and University of New South Wales Sydney has found that the level of a type of white blood cell, called tumor-infiltrating lymphocytes, present in the tumors of patients with high-grade ovarian cancer may predict a patient's survival.
› Verified 6 days ago